Video
Weight Management (Chapter 9)HbAc and weight management -
Wright AK, Kontopantelis E, Emsley R, Buchan I, Sattar N, Rutter MK, et al. Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups.
Diabetes Care. Article PubMed Google Scholar. American Diabetes A. Economic costs of diabetes in the U. in Article Google Scholar. American Diabetes Association Professional Practice C, Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, et al.
Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes Group LAR, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, et al.
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Wilding JP. The importance of weight management in type 2 diabetes mellitus.
Int J Clin Pract. Article CAS PubMed Google Scholar. Porter GC, Schwab R, Hill JL, Bartee T, Heelan KA, Michaud TL, et al. Examining the feasibility and characteristics of realistic weight management support for patients: focus groups with rural, micropolitan, and metropolitan primary care providers.
Prev Med Rep. Article PubMed PubMed Central Google Scholar. Finkelstein EA, Kruger E. Meta- and cost-effectiveness analysis of commercial weight loss strategies. Webb VL, Wadden TA. Intensive lifestyle intervention for obesity: principles, practices, and results.
Chaudhry ZW, Doshi RS, Mehta AK, Jacobs DK, Vakil RM, Lee CJ, et al. Obes Rev. Article CAS PubMed PubMed Central Google Scholar. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, et al.
Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Kolotkin RL, Crosby RD, Kosloski KD, Williams GR.
Development of a brief measure to assess quality of life in obesity. Obes Res. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies.
Int J Obes Relat Metab Disord. Womble LG, Wadden TA, Chandler JM, Martin AR. Agreement between weekly vs. daily assessment of appetite. Fisher L, Hessler DM, Polonsky WH, Mullan J.
When is diabetes distress clinically meaningful? Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals.
Am J Clin Nutr. Holland-Carter L, Tuerk PW, Wadden TA, Fujioka KN, Becker LE, Miller-Kovach K, et al. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial.
J Diabetes Complications. Lenters-Westra E, Schindhelm RK, Bilo HJ, Groenier KH, Slingerland RJ. Differences in interpretation of haemoglobin A1c values among diabetes care professionals.
Neth J Med. CAS PubMed Google Scholar. Little RR, Rohlfing CL. The long and winding road to optimal HbA1c measurement. Clin Chim Acta. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al.
J Am Coll Cardiol. Foster GD, Wadden TA, Lagrotte CA, Vander Veur SS, Hesson LA, Homko CJ, et al. A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program.
Nutr Diabetes. Rock CL, Flatt SW, Pakiz B, Taylor KS, Leone AF, Brelje K, et al. Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial.
Mathiesen AS, Egerod I, Jensen T, Kaldan G, Langberg H, Thomsen T. Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Syndr Obes. Download references. We are grateful for the PBRC cores including intervention resources IR , clinical chemistry, and medical records for assisting with the completion of this work.
Pennington Biomedical Research Center, Baton Rouge, LA, USA. John W. Apolzan, Robbie A. Beyl, Frank L. Greenway, Melissa N. Virginia Commonwealth University School of Medicine, Richmond, VA, USA. Jessica Gokee LaRose, Edmond P. Tiffany Bullard, Gary D. Center for Weight and Eating Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, FL, USA. You can also search for this author in PubMed Google Scholar. JWA, JGL, SDA, FLG, TB, and GDF contributed to the development of the study concept and design.
All authors contributed to data acquisition and interpretation. RAB performed the analysis. JWA and MIC contributed to drafting of the manuscript. All authors contributed to critical revision of the manuscript of important intellectual content. JWA is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Correspondence to John W. JWA: Grants NIH NIDDK and NIMHD, NSF, and USDA. JGL: Grants NIH NIDDK. Grants: NovMeta Pharma. GDF: Employee and Shareholder at WW. MIC: Grants: National Institute of Health NHLBI and NIDDK.
Employee at WW International, Inc. JULIANA MEYERS JULIANA MEYERS. Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. View large Download slide. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
View Metrics. Email alerts Article Activity Alert. Online Ahead of Print Alert. Latest Issue Alert. Most Read Most Cited MRI Metrics of Cerebral Endothelial Cell—Derived Exosomes for the Treatment of Cognitive Dysfunction Induced in Aging Rats Subjected to Type 2 Diabetes.
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Genetic Influences of Adiponectin on Insulin Resistance, Type 2 Diabetes, and Cardiovascular Disease. Online ISSN X Print ISSN Books ShopDiabetes. org ADA Professional Books Clinical Compendia Clinical Compendia Home News Latest News DiabetesPro SmartBrief.
Resources ADA Professional Membership ADA Member Directory Diabetes. X Twitter Facebook LinkedIn. Key Messages for People with Diabetes When you have diabetes, having overweight or obesity increases your risk for complications.
Healthy behaviour modifications, including regular physical activity and eating well can help with your blood glucose control and reduce your risk for other health problems associated with diabetes. Your diabetes health-care team can help you with weight management.
For some people with diabetes, weight management medications and bariatric surgery may be helpful. Introduction Obesity is a chronic health problem that is often progressive and difficult to treat. Treatment of Overweight and Obesity The goals of therapy for people with diabetes and overweight or obesity are to achieve optimal glycemic and metabolic control and, ultimately, improve quality of life, morbidity and mortality.
Healthy Behaviour Interventions Healthy behaviour interventions are essential components of successful weight management. Pharmacotherapy The effect of antihyperglycemic medication on body weight varies by class of medication. Figure 1 Gastric sleeve.
Figure 2 Roux-en-Y gastric bypass. Figure 3 Biliopancreatic diversion with duodenal switch. Bariatric Surgery Bariatric surgery is a therapeutic option in the management of people with type 2 diabetes and obesity. Recommendations For people with overweight or obesity who have or are at risk for diabetes, an interprofessional weight management program is recommended to prevent weight gain and improve CV risk factors [Grade A, Level 1A 24,28 ].
Other Relevant Guidelines Chapter 5. Reducing the Risk of Developing Diabetes Chapter Physical Activity and Diabetes Chapter Nutrition Therapy Chapter Author Disclosures Dr.
References Wing RR. Weight loss in the management of type 2 diabetes. In: Gerstein HC, Hyanes B, eds. Evidence-based diabetes care. Hamilton: B. Decker Inc. Conway B, Miller RG, Costacou T, et al. Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med ;— UK Prospective Diabetes Study UKPDS Group.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS Lancet ;— Ruderman N, Chisholm D, Pi-Sunyer X, et al.
The metabolically obese, normalweight individual revisited. Diabetes ;— Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality.
N Engl J Med ;—7. Markovic TP, Jenkins AB, Campbell LV, et al. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
Diabetes Care ;— Health Canada. Canadian guidelines for body weight classification in adults. Ottawa: , pg. Report No. Rabkin SW, Chen Y, Leiter L, et al. Risk factor correlates of body mass index.
Canadian Heart Health Surveys Research Group. CMAJ ; Suppl. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser ;i—xii, Reeder BA, Senthilselvan A, Despres JP, et al.
The association of cardiovascular disease risk factors with abdominal obesity in Canada. CMAJ ;S39— Treatment of obesity: Need to focus on high risk abdominally obese patients. BMJ ;— Expert Panel on Detection Evaluation, Treatment of High Blood Cholesterol in Adults.
Executive summary of the third report of the National Cholesterol Education Program NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults adult treatment panel III. JAMA ;— Grundy SM, Cleeman JI, Daniels SR, et al.
Circulation ;— International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF Communications, Hollander P.
Anti-diabetes and anti-obesity medications: Effects on weight in people with diabetes. Diabetes Spectr ;— Gorin AA, Niemeier HM, Hogan P, et al. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: Results from the Look AHEAD trial.
Arch Gen Psychiatry ;— Ribisl PM, Lang W, Jaramillo SA, et al. Grunstein RR, Stenlof K, Hedner JA, et al. Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity.
Sleep ;— Wing RR, Marcus MD, Epstein LH, et al. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care ;—6.
Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis. Am J Clin Nutr ;—8.
Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord ;— Elmer PJ, Grimm R Jr, Laing B, et al. Lifestyle intervention: Results of the Treatment of Mild Hypertension Study TOMHS.
Prev Med ;— Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med ;— Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Lau DCW, Douketis JD,Morrison KM, et al. CMAJ ;—9. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. Ahnis A, Figura A, Hofmann T, et al. Surgically and conservatively treated obese patients differ in psychological factors, regardless of body mass index or obesityrelated co-morbidities: A comparison between groups and an analysis of predictors.
PLoS ONE ;e Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Four-year results of the Look AHEAD trial. Arch Intern Med ;— Look Ahead Research Group. Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study.
Obesity Silver Spring ;— The American Diabetes Association ADA has been actively involved in the development and dissemination of diabetes care standards, guidelines, and related documents for many years. Diabetes Care ;35 Suppl 1:S1—2. WillettWC, Dietz WH, Colditz GA.
Guidelines for healthy weight. Williamson DF, Thompson TJ, Thun M, et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care ;— Pavlou KN, Krey S, Steffee WP.
Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr ;—
Thank you Manafement visiting nature. You are using weighh browser version with HbAc and weight management Flavonoids and cognitive function for CSS. To ad the best experience, we recommend you use a more up to date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes T2D. This was a single arm, three-site clinical trial. Primary outcome was change in HbA1c at 24 weeks. Prediabetes is a HbAc and weight management in managdment blood glucose sugar levels are higher than mabagement but not considered snd 2 diabetes. It is a precursor of type 2 diabetes. One of Herbal tea for menopause recommended lifestyle changes for HbAc and weight management and reversing prediabetes is weight loss as it can improve glycaemic control. Weight loss can help improve glycaemic control by making cells more responsive to insulin, reducing inflammation, decreasing excessive glucose production by the liver, and enhancing the function of insulin-producing beta cells. For those of you that are unfamiliar, insulin plays a crucial role in maintaining normal blood glucose levels by allowing cells in the body, particularly muscle, fat, and liver cells, to absorb glucose from the bloodstream.
die Interessante Variante